This year is a critical time for determining the future of clinical and translational cancer research in Aotearoa NZ. This includes both challenges and opportunities arising from major revisions to our healthcare system: the expectation that research becomes a core activity of Health NZ and the Māori Health Authority, the HRC/MOH project ‘Enhancing New Zealand’s Clinical Trials’, the broadening role of Te Aho o te Kahu, and the recognition of the need for improved National data governance which embeds Māori data sovereignty. To make the most of these changes, Cancer Trials NZ is holding a special meeting to bring together people interested in clinical and translational cancer research to discuss the role of cancer trials and cancer clinical research in Aotearoa NZ. How could these best operate in the new healthcare environment, and what infrastructure is needed to serve our needs for the next 20 years?
This focussed meeting will be in place of our usual Annual Scientific Meeting.
In person* and online attendance available - please select your preference when registering
*in person limited to 80 people
